Simtrol shares increased 9.52% as investors’ interest in the company increases. The company’s products enable their customers to control, monitor, diagnose, schedule and manage devices in a powerful, uniform way with better pricing and improved functionality than its competitors.
Simtrol’s products appeals to multiple markets because of their many applications. In the Government market, the company’s Curiax Arraigner software enables government agencies to provide courtrooms and jails with an alternative way to deal with problems associated with the transport of prisoners.
The company estimates that their potential revenue for its application in the government market alone to be $500 million. Its strategic marketing strategy leverages the sales and marketing teams from their partners, IBM, Polycom, NASI and SAIC, to reach over 3,000 counties.
The multibillion-dollar Healthcare market also gives the company significant opportunity to grow. Using Simtrol’s rich media applications, surgeons can collaborate images of live surgeries via high definition videoconferencing with colleagues and medical students around the globe.
The company’s go-to-market strategy to license its software to medical companies such as Stryker, Smith & Nephew, Sony, Karl Storz, Olympus, and Skytron, enables them to embed Simtrol’s software into their advanced operating room solutions. This strategy allows Simtrol to focus on continued product development while leveraging the sales and marketing teams from established market leaders.
Please share your thoughts: Simtrol Message Board
